Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

I really thought Camostat mesilate was going to be looked at


I think it is only approved for treatment in Japan


But it has been around for at least 20 years. The safety profile is extremely well known.


I don't even want to know what role lobbyists play in selecting the drugs used for the trial.


Clearly if they played a big role they did a terrible job with how many of these drugs are off patent.


Probably not a lot. Most of these are out of patent.


I guarantee you that Gilead has at least considered filing a patent application on a new use of the old compound. And they will probably get a grant. Same for all the other treatments.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: